Therapies for neurologic erectile dysfunction.

Expert Rev Neurother

Department of Urology, Mayo Clinic, 200 1stStreet SW, Rochester, MN 55905 USA.

Published: September 2003

A subset of men with erectile dysfunction have an underlying neurologic or neurodegenerative condition which directly causes their impairment. The authors briefly discuss the interplay of the CNS, peripheral nervous system and corporal bodies of the penis integral to normal erectile function and how these interactions are disrupted in the setting of various neurologic conditions. Effective therapies for these patients exist in a variety of different forms to include oral or injectable drugs and even surgery. Future treatment strategies will focus on the improvement of existing therapies as well as the invention of new long-term therapeutic options.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.3.5.641DOI Listing

Publication Analysis

Top Keywords

erectile dysfunction
8
therapies neurologic
4
neurologic erectile
4
dysfunction subset
4
subset men
4
men erectile
4
dysfunction underlying
4
underlying neurologic
4
neurologic neurodegenerative
4
neurodegenerative condition
4

Similar Publications

Introduction: Pelvic ring fractures are known to be associated with complications associated with adjacent organ injuries, such as the urogenital tract (e.g. erectile dysfunction (ED), which are sometimes diagnosed in a delayed fashion.

View Article and Find Full Text PDF

Objective: Erectile dysfunction (ED) is a common cause of male sexual dysfunction. We aimed to evaluate the quality of ChatGPT and Gemini's responses to the most frequently asked questions about ED.

Methods: This study was conducted as a cross-sectional, observational study.

View Article and Find Full Text PDF

A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004.

Front Endocrinol (Lausanne)

January 2025

The Second Department of Infectious Disease, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Background: Erectile dysfunction (ED) is characterized by the inability to achieve or maintain penile erection sufficient for intercourse. While previous research suggests a potential link between ED and prostate pathologies, the association between benign prostatic hyperplasia (BPH), prostatitis, prostatic cancer (PCa), and ED remains to be elucidated.

Methods: Data from participants (40-80 years, n=2225) were extracted from the NHANES 2001-2004 for this observational study.

View Article and Find Full Text PDF

Background: Cavernous nerve injury-induced erectile dysfunction (CNI-ED) is a common complication following radical prostatectomy and severely affects patients' quality of life. The mitochondrial impairment in corpus cavernosum smooth muscle cells (CCSMCs) may be an important pathological mechanism of CNI-ED. Previous studies have shown that transplantation of human adipose derived stem cells (ADSC) can alleviate CNI-ED in a rat model.

View Article and Find Full Text PDF

The ejaculatory reflex consists of emission and expulsion, with the latter involving rhythmic muscular contractions that propel seminal fluid. Botulinum toxin, through its inhibitory effects, has been hypothesized to improve premature ejaculation (PE). This study evaluates high-quality evidence on botulinum toxin-A injections into the bulbospongiosal muscle as a treatment for PE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!